Table V.
Frequency of hypogonadism among patients currently using glucocorticoids compared with individuals who had never used glucocorticoids.
| Hypogonadism, n (%) | |||||
|---|---|---|---|---|---|
| Treatments | Yes | No | Odds ratio | Confidence interval | P-value |
| Glucocorticoid | 4.34 | 1.67-11.31 | <0.001c | ||
| User | 23 (40.4) | 34 (59.6) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Prednisolone PO | 8.57 | 1.57-46.71 | 0.018a | ||
| User | 4 (57.1) | 3 (42.9) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Dexamethasone PO | 2.87 | 1.26-6.52 | 0.009b | ||
| User | 12 (38.7) | 19 (61.3) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Dexamethasone PO, Cumulative dose | 7.5 | 1.46-38.28 | 0.015a | ||
| ≥18.9 mg | 8 (66.7) | 4 (33.3) | |||
| <18.9 mg | 4 (21.1) | 15 (78.9) | |||
| Dexamethasone injection | 1.85 | 0.29-11.6 | 0.47 | ||
| User | 1(25) | 3(75) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Methylprednisolone acetate injection | 3.3 | 1.2-9.01 | 0.047a | ||
| User | 4 (44.4) | 5 (55.6) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Betamethasone acetate injection | 4.33 | 1.87-10.02 | 0.002b | ||
| User | 7 (58.3) | 5 (41.7) | |||
| Not user | 7 (13.5) | 45 (86.5) | |||
| Total cumulative equivalent dose | 3.72 | 1.05-13.22 | 0.038a | ||
| ≥240 mg | 9 (64.3) | 5 (35.7) | |||
| <240 mg | 14 (32.6) | 29 (67.4) | |||
aP<0.05,
bP<0.01,
cP<0.001. PO, per Orem.